
Mad Money w/ Jim Cramer 1/22/24
Mad Money w/ Jim Cramer
00:00
Analysis of Tesla's stock decline, Eli Lilly's stock advance, Catalyst Pharmaceuticals, Dancing Jens and Wong, cybersecurity space, and upcoming CEO interview
The hosts discuss the decline of Tesla's stock, the challenges it faces as an EV company, and suggest revising investment strategies. They also analyze Catalyst Pharmaceuticals' potential, talk about the cybersecurity space in light of Microsoft's breach, and promote their show with sponsored ads.
Transcript
Play full episode